Company Says It Will Cooperate With Authorities in Investigation

BEIJING—GlaxoSmithKline said some of its senior executives appeared to have violated Chinese law, after Chinese officials alleged the company was involved in widespread bribery in the country.

Abbas Hussain, Glaxo's London-based president of emerging markets and Asia Pacific, met with Chinese authorities over the weekend, according to a Glaxo statement Monday. The statement added: "Certain senior executives of GSK China who know our systems well, appear to have acted outside of our processes and controls which...